Cargando…
Formulation and in vitro and in vivo evaluation of film-coated montelukast sodium tablets using Opadry(®) yellow 20A82938 on an industrial scale
PURPOSE: The aim of this study was to formulate stable film-coated montelukast sodium (MS) tablets using Opadry(®) yellow 20A82938 (Montikast(®) tablets) and to evaluate their in vitro and in vivo release profile. METHODS: MS core tablets were manufactured using a direct compression method. Opadry y...
Autores principales: | Zaid, Abdel Naser, Natour, Salam, Qaddomi, Aiman, Abu Ghoush, Abeer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573806/ https://www.ncbi.nlm.nih.gov/pubmed/23430138 http://dx.doi.org/10.2147/DDDT.S37369 |
Ejemplares similares
-
Formulation and Bioequivalence of Two Valsartan Tablets After a Single Oral Administration
por: Zaid, Abdel Naser, et al.
Publicado: (2011) -
Design, Formulation, and Physicochemical Evaluation of Montelukast Orally Disintegrating Tablet
por: Aslani, Abolfazl, et al.
Publicado: (2016) -
Bioequivalence of the 4-mg Oral Granules and Chewable Tablet Formulations of Montelukast
por: Knorr, Barbara, et al.
Publicado: (2010) -
Fast Disintegrating Combination Tablet of Taste Masked Levocetrizine Dihydrochloride and Montelukast Sodium: Formulation Design, Development, and Characterization
por: Gupta, M. M., et al.
Publicado: (2014) -
Interchangeability and comparative effectiveness between generic and brand montelukast immediate release tablets after a single oral administration in healthy volunteers
por: Zaid, Abdel Naser, et al.
Publicado: (2015)